An Abstract on Social Anxiety Disorder by Dr. Mark Pollack:
Journal of Clinical Psychiatry 2001;62 Suppl 12:24-9
Comorbidity, Neurobiology, and Pharmacotherapy of Social Anxiety disorder.
Pollack MH, Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston 02114
Social anxiety disorder is a common psychiatric illness that imposes persistent functional impairment and disability on persons who have the disorder. The disorder is characterized by a marked and persistent fear of social or performance situations in which embarrassment may occur. It is the most prevalent of any anxiety disorders and is the third most common psychiatric disorder after depression and alcohol abuse. Social anxiety disorder typically begins during childhood with a mean age at onset between 14 and 16 years and is sometimes preceded by a history of social inhibition or shyness. Persons who have social anxiety disorder either endure or avoid social situations altogether because the fear of embarrassment causes such intense anxiety; such avoidance may ultimately interfere with occupational and/or social functioning and lead to significant disability. The duration of social anxiety disorder is frequently lifelong, and there is a high degree of comorbidity with other psychiatric disorders. Social anxiety disorder is a serious illness that frequently runs a chronic course and is associated with significant morbidity. Patients should be treated aggressively using pharmacotherapeutic agents that can be tolerated over the long term. Cognitive-behavioral therapy should also be considered in treatment planning. Efforts to increase the recognition of social anxiety disorder as a common, distressing, and disabling condition are critical. This article discusses the comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.
Two SSRI's (Paxil and Zoloft) and one SNRI (Effexor) are the only drugs FDA approved for the treatment of Social Anxiety Disorder as of 2026.
Unfortunately SRI's are at best usually only MILDLY to MODERATELY helpful for the treatment of SAD. They are considered the "first line" treatment for Social Anxiety Disorder primarily because doctors usually perceive them as the safest of available drug treatments. Also, SRI's are often very good at treating some other anxiety and depressive disorders which are often comorbid with (accompany) SAD, such as Dysthymia, Depression, Panic Disorder, and Generalized Anxiety Disorder (GAD).
Prozac (fluoxetine): The most activating SSRI.
Zoloft (sertraline): A popular SSRI for treating Social Anxiety.
Paxil (paroxetine): Another commonly prescribed SSRI for Social Anxiety.
Celexa (citalopram): May have fewer side effects than SSRI's listed above.
Lexapro (escitaloram): A "knockoff" SSRI derived from Celexa above.
These include Effexor, Cymbalta, Pristiq, Remeron, Wellbutrin, and others. They all mainly affect serotonin and/or norepinephrine.
Effexor(venlafaxine): A popular SRI treatment for social anxiety.
Pristiq (desvenlafaxine): A copycat SRI derived from Effexor.
Cymbalta (duloxetine): Not commonly used to treat Social Anxiety.
Remeron (mirtazapine): Not commonly used, frankly, for anything.
Wellbutrin (bupropion): Not recommended for Social Anxiety! Likely to make it worse!
The MAOI "Nardil" is definitely the most powerful and effective antidepressant for Social Anxiety Disorder.
Nardil (phenelzine): Nardil usually works great for SAD! Nardil is considered the "Gold Standard" treatment for SAD. Reports of Nardil side effects are often ridiculously exaggerated. It is very important to be treated with a high enough dose. It also is important to know that side effects may take 3 or 4 months to maximally diminish. Effective dose range for SAD can be from 45 - 105 mg/day, and is positively correlated with a person's weight. MAOI related "hypertensive crisis" is very rare with modern food standards (and it was rare in 1960 too)! Here is a somewhat up to date abstract discussing the "MAOI diet".
Parnate (tranylcypromine): Parnate is not as effective as Nardil for SAD, but occasionally may work well. It is a very activating, dopaminergic antidepressant.
Emsam / Eldepryl (selegiline): Emsam is relatively unstudied for the treatment of Social Anxiety Disorder. There is no reason to think it would be any more effective than Parnate if taken at comparable doses.
Aurorix (moclobemide): Moclobemide is a 'reversible' MAOI. It has not proven to be an effective treatment for SAD.
Long term use of benzodiazepines remains controversial. About 10 are available but Klonopin is by far the most effective for SAD. Xanax is sometimes helpful also.
Klonopin (clonazepam): Klonopin is very effective for SAD and usually works great. Klonopin can be taken either "as needed" or everday. "As needed" (prn) use can be done up to twice per week, and will usually provide excellent effect within 30 minutes, lasting several hours to 1/2 day. Long term (everyday) use is more controversial.
Xanax (alprazolam): May be helpful. Xanax has a short half life which may limit its utility in long term use.